Damora Therapeutics (DMRA) Appoints Jennifer Jarrett as President, Chief Executive Officer

9 hours ago 1

Maham Fatima

Tue, May 5, 2026 astatine 12:05 PM CDT 2 min read

Damora Therapeutics Inc. (NASDAQ:DMRA) is 1 of the best performing NASDAQ stocks according to Wall Street analysts. On March 23, Damora Therapeutics appointed Jennifer Jarrett arsenic President and Chief Executive Officer, effectual March 30. Jarrett, who volition besides articulation the Board of Directors, antecedently served arsenic COO and CFO astatine Arcus Biosciences and held enforcement roles astatine Uber and Medivation. Her inheritance successful oncology cause improvement and concern banking is expected to accelerate the improvement of DMR-001, the company’s pb programme for mutant calreticulin-driven humor disorders.

In summation to the caller CEO, the institution has expanded its Board of Directors with the appointments of Dr. Cameron Turtle and Mike Landsittel. Dr. Turtle presently serves arsenic CEO of Spyre Therapeutics, portion Landsittel is the erstwhile CFO of Blueprint Medicines. Simultaneously, Peter Harwin, a founding spouse astatine Fairmount Funds Management, has been named Chairman of the Board, succeeding departing directors Dr. Carl Goldfischer, Dr. Jayson Dallas, and Amit Munshi.

Damora Therapeutics (DMRA) Appoints Jennifer Jarrett arsenic President, Chief Executive Officer

These enactment changes travel the caller transaction betwixt Damora and Galecto, signaling a strategical displacement toward accelerated objective advancement and commercialized readiness. The caller squad volition oversee a portfolio aimed astatine redefining attraction for myeloproliferative neoplasms. With a reinforced committee and enforcement leadership, the institution plans to leverage its beardown equilibrium expanse to beforehand its pipeline assets and present worth to shareholders.

Damora Therapeutics Inc. (NASDAQ:DMRA) is simply a biotech institution focused connected redefining attraction for hematologic disorders. The institution is advancing a caller procreation of biologics targeting mutant calreticulin-driven myeloproliferative neoplasms, specified arsenic indispensable thrombocythemia and myelofibrosis.

While we admit the imaginable of DMRA arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy.

Disclosure: None. Follow Insider Monkey connected Google News.

Read Entire Article